Clinical Trials Directory

Trials / Sponsors / Manhattan Eye, Ear & Throat Hospital

Manhattan Eye, Ear & Throat Hospital

Academic / Other · 17 registered clinical trials.

StatusTrialPhaseStarted
WithdrawnIntravitreal Aflibercept Injections In The Treatment Of Pattern Dystrophy
Pattern Dystrophy of Macula
N/A2013-10-01
UnknownICG-Guided Photodynamic Therapy for Treatment of Retinal Capillary Abnormalities: A Pilot Study
Retinal Vascular Disorders
N/A2013-04-01
CompletedTreatment of Pseudovitellium Detachment With Open-Label Anecortave Acetate Sterile Suspension (15 mg)
Pseudovitellium Detachment, Eye Diseases
Phase 22008-04-01
CompletedTreatment of Chronic Central Serous Chorioretinopathy With Open-Label Anecortave Acetate
Chronic Central Serous Chorioretinopathy
Phase 1 / Phase 22007-05-01
CompletedTreatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Ma
Coats' Disease, Idiopathic Retinal Telangiectasia, Retinal Angiomatous Proliferation
Phase 1 / Phase 22007-05-01
CompletedTreatment of Age-Related Macular Degeneration With Anecortave Acetate
Macular Degeneration
Phase 22005-09-01
CompletedA Pilot Study of the Treatment of Central Serous Chorioretinopathy With Ketoconazole
Chronic Central Serous Chorioretinopathy
Phase 22005-05-01
TerminatedTreatment of Radiation Retinopathy With Open-Label Anecortave Acetate Sterile Suspension (15 mg)
Eye Injuries
Phase 22004-04-01
CompletedStudy Of Combined VISUDYNE Therapy With Kenalog In CNV Secondary To Age-Related Macular Degeneration
Age-Related Macular Degeneration
Phase 22003-10-01
CompletedTreatment of Conditions With Open Label-Anecortave Acetate Sterile Suspension ( 15mg.) Where Lesions do Not Me
Age-Related Macular Degenerations., Subfoveal Neovascularization.
Phase 22003-05-01
CompletedPhotodynamic Therapy Using Verteporfin for Treatment of Chronic Central Serous Chorioretinopathy (CSC)
Chronic Central Serous Chorioretinopathy
Phase 22002-07-01
CompletedTreatment of Idiopathic Perifoveal Telangiectasia (IPT) With Open-Label Anecortave Acetate (15mg.).
Idiopathic Perifoveal Telangiectasia
Phase 22002-03-01
TerminatedTreatment of Rubeosis Iridis With Open-Label Anecortave Acetate Sterile Suspension ( 15 mg.).
Severe Diabetic Retinopathy, Central Retinal Vein Occlusion, Chronic Inflammation
Phase 22002-03-01
WithdrawnTreatment of Retinal Vein Occlusion (RVO) With Open-Label Anecortave Acetate (15mg.)
Retinal Vein Occlusion
Phase 22002-03-01
CompletedTreatment of Congenital Telangiectasia (Coat's Disease) With Open-label Anecortave Acetate (15mg.)
Coat's Disease
Phase 22002-03-01
CompletedStudy of the Combination of Anecortave Acetate and Triamcinolone Acetonide for the Treatment of Exudative Age-
Maculopathy, Age-Related
Phase 1—
TerminatedTreatment of Diabetic Retinopathy With Open-Label Anecortave Acetate Sterile Suspension (15 mg)
Diabetic Retinopathy
Phase 1—